- Home
- Â /Â Viveve
Viveve
Stock Price
$0
2024-10-29
Market Capitalization
$4.3 K
2024-10-29
Revenue
$6.4 M
FY, 2021
Viveve Summary
Company Summary
- Overview
- Viveve is a women's health and wellness company. It offers a non-surgical, non-ablative medical device that remodels collagen and restores vaginal tissue. The Company also develops cryogen-cooled monopolar RF energy technology.
- Type
- Public
- Status
- Active
- Founded
- 2005
- HQ
- Englewood, CO, US | view all locations
- Website
- http://www.viveve.com
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Suzon Lommel, Senior Vice President of Regulatory and Quality Affairs
Jim Robbins, Senior Vice President of Finance & Administration, Principal Accounting & Financial Officer
Doug Massey, Vice President of Clinical and Medical Affairs
LocationsView all
1 location detected
Englewood, COÂ HQ
United States
345 Inverness Dr S building b, suite 250
Viveve Financials
Summary Financials
- Revenue (Q3, 2022)
- $1.7M
- Gross profit (Q3, 2022)
- $546.0K
- Net income (Q3, 2022)
- ($5.0M)
- Cash (Q3, 2022)
- $5.9M
- EBIT (Q3, 2022)
- ($4.7M)
- Enterprise value
- ($274.7K)